deltatrials
Completed OBSERVATIONAL NCT06812559

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

Progesterone Primed Ovarian Stimulation Versus Gonadotrophin-Releasing Hormone Antagonist in Women With Polycystic Ovarian Syndrome

Sponsor: El Shatby University Hospital for Obstetrics and Gynecology

Conditions Controlled Ovarian Hyperstimulation Polycystic Ovarian Syndrome
Interventions GnRH antagonist (Cetrorelix) Progesterone
Updated 2 times since 2025 Last updated: Feb 21, 2025 Started: Dec 1, 2023 Primary completion: Feb 1, 2025 Completion: Feb 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Controlled Ovarian Hyperstimulation and Polycystic Ovarian Syndrome and is currently completed. El Shatby University Hospital for Obstetrics and Gynecology leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshotCompleted~Jun 2025 – present · 13 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed

  2. Mar 2025 — Jun 2025 [monthly]

    Completed

    First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • El Shatby University Hospital for Obstetrics and Gynecology
Data source: El Shatby University Hospital for Obstetrics and Gynecology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations